

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ketone body metabolic process (GO:1902224) | 9.98682090 |
| 2 | * secondary metabolic process (GO:0019748) | 9.94482772 |
| 3 | melanocyte differentiation (GO:0030318) | 8.27905020 |
| 4 | * developmental pigmentation (GO:0048066) | 7.92171076 |
| 5 | pigment cell differentiation (GO:0050931) | 7.54171749 |
| 6 | melanosome organization (GO:0032438) | 7.35738962 |
| 7 | * pigment biosynthetic process (GO:0046148) | 7.14464617 |
| 8 | pigment granule organization (GO:0048753) | 6.99574773 |
| 9 | regulation of endothelial cell chemotaxis (GO:2001026) | 6.12862597 |
| 10 | myotube differentiation (GO:0014902) | 5.60320671 |
| 11 | * pigment metabolic process (GO:0042440) | 5.51437561 |
| 12 | mesenchymal-epithelial cell signaling (GO:0060638) | 5.46458306 |
| 13 | endosome to pigment granule transport (GO:0043485) | 5.42674043 |
| 14 | endosome to melanosome transport (GO:0035646) | 5.42674043 |
| 15 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 5.33636942 |
| 16 | neuroepithelial cell differentiation (GO:0060563) | 5.32046939 |
| 17 | melanosome transport (GO:0032402) | 5.26119618 |
| 18 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 5.19642568 |
| 19 | regulation of superoxide anion generation (GO:0032928) | 5.12456556 |
| 20 | pigment granule transport (GO:0051904) | 5.07584673 |
| 21 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.05522455 |
| 22 | establishment of melanosome localization (GO:0032401) | 4.99944311 |
| 23 | melanosome localization (GO:0032400) | 4.98963697 |
| 24 | positive regulation of neuroblast proliferation (GO:0002052) | 4.95923453 |
| 25 | short-chain fatty acid metabolic process (GO:0046459) | 4.85806706 |
| 26 | negative regulation of response to reactive oxygen species (GO:1901032) | 4.84876240 |
| 27 | pigment granule localization (GO:0051875) | 4.83739183 |
| 28 | establishment of pigment granule localization (GO:0051905) | 4.83353291 |
| 29 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 4.79219258 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.71097986 |
| 31 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.57464032 |
| 32 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 4.43454811 |
| 33 | negative regulation of interleukin-1 beta production (GO:0032691) | 4.41146720 |
| 34 | endothelial cell morphogenesis (GO:0001886) | 4.20155276 |
| 35 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.14252864 |
| 36 | response to epinephrine (GO:0071871) | 4.04209086 |
| 37 | nerve growth factor signaling pathway (GO:0038180) | 4.04121737 |
| 38 | * melanin biosynthetic process (GO:0042438) | 32.9741383 |
| 39 | positive regulation of receptor recycling (GO:0001921) | 3.86274932 |
| 40 | * phenol-containing compound metabolic process (GO:0018958) | 3.74007088 |
| 41 | semaphorin-plexin signaling pathway (GO:0071526) | 3.70190446 |
| 42 | somatic stem cell division (GO:0048103) | 3.53491297 |
| 43 | inositol phosphate catabolic process (GO:0071545) | 3.50048038 |
| 44 | negative regulation of interleukin-1 production (GO:0032692) | 3.49765852 |
| 45 | regulation of neuroblast proliferation (GO:1902692) | 3.46674281 |
| 46 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.44232398 |
| 47 | stress fiber assembly (GO:0043149) | 3.39329680 |
| 48 | negative regulation of chemokine production (GO:0032682) | 3.38901084 |
| 49 | regulation of superoxide metabolic process (GO:0090322) | 3.36643078 |
| 50 | * pigmentation (GO:0043473) | 3.26171220 |
| 51 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.22582105 |
| 52 | regulation of cellular respiration (GO:0043457) | 3.21044760 |
| 53 | inositol phosphate dephosphorylation (GO:0046855) | 3.20957521 |
| 54 | enteric nervous system development (GO:0048484) | 3.19719706 |
| 55 | signal peptide processing (GO:0006465) | 3.19288882 |
| 56 | negative regulation of JUN kinase activity (GO:0043508) | 3.18729670 |
| 57 | muscle cell migration (GO:0014812) | 3.17702600 |
| 58 | columnar/cuboidal epithelial cell differentiation (GO:0002065) | 3.17369847 |
| 59 | negative regulation of acute inflammatory response (GO:0002674) | 3.16733076 |
| 60 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.13164639 |
| 61 | acrosome reaction (GO:0007340) | 3.11084488 |
| 62 | regulation of somitogenesis (GO:0014807) | 3.09568533 |
| 63 | barbed-end actin filament capping (GO:0051016) | 3.09137007 |
| 64 | response to thyroid hormone (GO:0097066) | 3.05170354 |
| 65 | * melanin metabolic process (GO:0006582) | 29.6530155 |
| 66 | * secondary metabolite biosynthetic process (GO:0044550) | 26.9265726 |
| 67 | mitotic G1/S transition checkpoint (GO:0044819) | 2.98366728 |
| 68 | G1 DNA damage checkpoint (GO:0044783) | 2.94509152 |
| 69 | fibroblast migration (GO:0010761) | 2.91957982 |
| 70 | cullin deneddylation (GO:0010388) | 2.80795620 |
| 71 | dosage compensation (GO:0007549) | 2.80214882 |
| 72 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.79397125 |
| 73 | proline transport (GO:0015824) | 2.79188128 |
| 74 | negative regulation of organelle assembly (GO:1902116) | 2.78999947 |
| 75 | polyol catabolic process (GO:0046174) | 2.77124376 |
| 76 | piRNA metabolic process (GO:0034587) | 2.76282140 |
| 77 | bone remodeling (GO:0046849) | 2.71578773 |
| 78 | cellular response to reactive nitrogen species (GO:1902170) | 2.71215503 |
| 79 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.68117622 |
| 80 | cellular response to nitric oxide (GO:0071732) | 2.66884213 |
| 81 | Rap protein signal transduction (GO:0032486) | 2.65195260 |
| 82 | response to muscle activity (GO:0014850) | 2.65000981 |
| 83 | behavioral response to ethanol (GO:0048149) | 2.61623121 |
| 84 | retinal rod cell development (GO:0046548) | 2.61362729 |
| 85 | regulation of response to reactive oxygen species (GO:1901031) | 2.59740960 |
| 86 | negative regulation of oxidative stress-induced cell death (GO:1903202) | 2.58976391 |
| 87 | basement membrane organization (GO:0071711) | 2.58596541 |
| 88 | peripheral nervous system development (GO:0007422) | 2.58539002 |
| 89 | galactose metabolic process (GO:0006012) | 2.57862189 |
| 90 | intracellular pH reduction (GO:0051452) | 2.57414789 |
| 91 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.57353639 |
| 92 | proteasome assembly (GO:0043248) | 2.55015966 |
| 93 | negative regulation of TOR signaling (GO:0032007) | 2.54891368 |
| 94 | plasma membrane fusion (GO:0045026) | 2.51007715 |
| 95 | positive regulation of neural precursor cell proliferation (GO:2000179) | 2.50081617 |
| 96 | negative regulation of cellular response to oxidative stress (GO:1900408) | 2.48910730 |
| 97 | negative regulation of response to oxidative stress (GO:1902883) | 2.48910730 |
| 98 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.46389887 |
| 99 | muscle cell cellular homeostasis (GO:0046716) | 2.43425526 |
| 100 | Rac protein signal transduction (GO:0016601) | 2.41701493 |
| 101 | protein deneddylation (GO:0000338) | 2.40965748 |
| 102 | inner mitochondrial membrane organization (GO:0007007) | 2.40017767 |
| 103 | regulation of DNA endoreduplication (GO:0032875) | 2.39541368 |
| 104 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.38344199 |
| 105 | response to nerve growth factor (GO:1990089) | 2.38344199 |
| 106 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.38060660 |
| 107 | sialylation (GO:0097503) | 2.34419458 |
| 108 | regulation of centriole replication (GO:0046599) | 2.33404115 |
| 109 | removal of superoxide radicals (GO:0019430) | 2.33106603 |
| 110 | cellular response to superoxide (GO:0071451) | 2.33106603 |
| 111 | cellular response to oxygen radical (GO:0071450) | 2.33106603 |
| 112 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.32627121 |
| 113 | vesicle localization (GO:0051648) | 2.32365546 |
| 114 | regulation of receptor recycling (GO:0001919) | 2.31259913 |
| 115 | response to nitric oxide (GO:0071731) | 2.30251488 |
| 116 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.30217208 |
| 117 | positive regulation of response to oxidative stress (GO:1902884) | 2.30217208 |
| 118 | dendritic spine organization (GO:0097061) | 2.29765686 |
| 119 | glutathione derivative metabolic process (GO:1901685) | 2.28446016 |
| 120 | glutathione derivative biosynthetic process (GO:1901687) | 2.28446016 |
| 121 | autophagic vacuole fusion (GO:0000046) | 2.28375284 |
| 122 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.28343591 |
| 123 | gluconeogenesis (GO:0006094) | 2.27181701 |
| 124 | regulation of protein sumoylation (GO:0033233) | 2.26526085 |
| 125 | stem cell division (GO:0017145) | 2.26298283 |
| 126 | 4-hydroxyproline metabolic process (GO:0019471) | 2.24280283 |
| 127 | establishment of nucleus localization (GO:0040023) | 2.23358929 |
| 128 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.21911331 |
| 129 | osteoclast differentiation (GO:0030316) | 2.17559671 |
| 130 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.03201346 |
| 131 | positive regulation of glucose transport (GO:0010828) | 2.02781379 |
| 132 | myelin assembly (GO:0032288) | 2.00623061 |
| 133 | tyrosine metabolic process (GO:0006570) | 15.0770116 |
| 134 | * phenol-containing compound biosynthetic process (GO:0046189) | 10.2412307 |
| 135 | regulation of early endosome to late endosome transport (GO:2000641) | 1.97451783 |
| 136 | * organic hydroxy compound biosynthetic process (GO:1901617) | 1.97263029 |
| 137 | folic acid-containing compound biosynthetic process (GO:0009396) | 1.96819627 |
| 138 | regulation of apoptotic cell clearance (GO:2000425) | 1.96185229 |
| 139 | cellular glucuronidation (GO:0052695) | 1.95339307 |
| 140 | positive chemotaxis (GO:0050918) | 1.90746585 |
| 141 | peptidyl-lysine dimethylation (GO:0018027) | 1.89242492 |
| 142 | establishment of mitotic spindle orientation (GO:0000132) | 1.88513737 |
| 143 | centrosome duplication (GO:0051298) | 1.88358639 |
| 144 | protein K6-linked ubiquitination (GO:0085020) | 1.86322026 |
| 145 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.85495323 |
| 146 | regulation of oxidative stress-induced cell death (GO:1903201) | 1.84342890 |
| 147 | negative regulation of histone methylation (GO:0031061) | 1.83012847 |
| 148 | positive regulation of osteoblast proliferation (GO:0033690) | 1.77406444 |
| 149 | negative regulation of membrane potential (GO:0045837) | 1.77051177 |
| 150 | glucuronate metabolic process (GO:0019585) | 1.74704024 |
| 151 | uronic acid metabolic process (GO:0006063) | 1.74704024 |
| 152 | positive regulation of Rap GTPase activity (GO:0032854) | 1.73063350 |
| 153 | organelle membrane fusion (GO:0090174) | 1.71873754 |
| 154 | glycolytic process (GO:0006096) | 1.71260397 |
| 155 | specification of organ identity (GO:0010092) | 1.71152348 |
| 156 | glycoprotein catabolic process (GO:0006516) | 1.69099271 |
| 157 | regulation of histone H3-K9 methylation (GO:0051570) | 1.68622889 |
| 158 | spinal cord association neuron differentiation (GO:0021527) | 1.67178894 |
| 159 | chondroitin sulfate biosynthetic process (GO:0030206) | 1.66250551 |
| 160 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 1.65985140 |
| 161 | establishment of mitotic spindle localization (GO:0040001) | 1.64650591 |
| 162 | regulation of cellular response to oxidative stress (GO:1900407) | 1.63557385 |
| 163 | glycogen biosynthetic process (GO:0005978) | 1.59686989 |
| 164 | glucan biosynthetic process (GO:0009250) | 1.59686989 |
| 165 | centrosome localization (GO:0051642) | 1.59639694 |
| 166 | regulation of translational fidelity (GO:0006450) | 1.59512617 |
| 167 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 1.58670532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.20114104 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.60251058 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.35142511 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.12987342 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.78231266 |
| 6 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 3.78020390 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.62212212 |
| 8 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.09228919 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.89137123 |
| 10 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.83557269 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.80709216 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.69601780 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.57402929 |
| 14 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.54186337 |
| 15 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.45481164 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.36795654 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.23262003 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.21818151 |
| 19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.20466956 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.12860376 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.10200371 |
| 22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.08104733 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.06836386 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04969567 |
| 25 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 10.9632179 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98222696 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.94740190 |
| 28 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.92607487 |
| 29 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.81316645 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.77926987 |
| 31 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.73188746 |
| 32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.71795960 |
| 33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.70916148 |
| 34 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.66641246 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.65604408 |
| 36 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.64171224 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63347445 |
| 38 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61971653 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57723847 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53622854 |
| 41 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.52102269 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51542068 |
| 43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.50316286 |
| 44 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.48505997 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.46552881 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.45278325 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43313084 |
| 48 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.42534120 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.41437100 |
| 50 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.41245984 |
| 51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38044561 |
| 52 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.37774205 |
| 53 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.35810589 |
| 54 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.35400006 |
| 55 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33466864 |
| 56 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32540491 |
| 57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29665587 |
| 58 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.26094477 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25918491 |
| 60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.25095262 |
| 61 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.24983397 |
| 62 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.23849205 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.23134507 |
| 64 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23063925 |
| 65 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22731626 |
| 66 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.22092753 |
| 67 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21219375 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20790419 |
| 69 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19873656 |
| 70 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.18282683 |
| 71 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17080255 |
| 72 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17080255 |
| 73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17014631 |
| 74 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.16921521 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14651728 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14438072 |
| 77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14170990 |
| 78 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13881454 |
| 79 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.12582066 |
| 80 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.12515434 |
| 81 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12340214 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11246206 |
| 83 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11018594 |
| 84 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10974370 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10603476 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10603476 |
| 87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10391302 |
| 88 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09507600 |
| 89 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.09473436 |
| 90 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09345041 |
| 91 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09228437 |
| 92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09008490 |
| 93 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08383637 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06470266 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05963754 |
| 96 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.05889887 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05484097 |
| 98 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04935744 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04153389 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01929827 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01670040 |
| 102 | JUN_21703547_ChIP-Seq_K562_Human | 1.01401785 |
| 103 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01214527 |
| 104 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.00434600 |
| 105 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99972572 |
| 106 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.99893300 |
| 107 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.99382928 |
| 108 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99234576 |
| 109 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99164355 |
| 110 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.98716787 |
| 111 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.98204458 |
| 112 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98138079 |
| 113 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97304976 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95957326 |
| 115 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94653447 |
| 116 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.94061293 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93693942 |
| 118 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93585071 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93378318 |
| 120 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92885275 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92788605 |
| 122 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91999806 |
| 123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91823462 |
| 124 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91653311 |
| 125 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.91365333 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90653782 |
| 127 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90362195 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90350765 |
| 129 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90197630 |
| 130 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90192064 |
| 131 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.89902803 |
| 132 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.89494520 |
| 133 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.89439390 |
| 134 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89307516 |
| 135 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88919552 |
| 136 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88434940 |
| 137 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88335891 |
| 138 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87765775 |
| 139 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87761667 |
| 140 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87501813 |
| 141 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87405772 |
| 142 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.87320402 |
| 143 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87005059 |
| 144 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.86931922 |
| 145 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86253820 |
| 146 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.85548574 |
| 147 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.85523041 |
| 148 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85344446 |
| 149 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.84953549 |
| 150 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.84380509 |
| 151 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83927028 |
| 152 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83537306 |
| 153 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.83205118 |
| 154 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83180078 |
| 155 | P300_19829295_ChIP-Seq_ESCs_Human | 0.82642647 |
| 156 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.82095859 |
| 157 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.81775152 |
| 158 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.81598655 |
| 159 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81061038 |
| 160 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.80887418 |
| 161 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80674046 |
| 162 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.80079446 |
| 163 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.79561424 |
| 164 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.78513059 |
| 165 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78506154 |
| 166 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.78238982 |
| 167 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.78228206 |
| 168 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78131501 |
| 169 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.77722518 |
| 170 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.77646878 |
| 171 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76546244 |
| 172 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.75428346 |
| 173 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.75369377 |
| 174 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.75310243 |
| 175 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75296631 |
| 176 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.74498122 |
| 177 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74232674 |
| 178 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.74189291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0000372_irregular_coat_pigmentation | 9.78489595 |
| 2 | MP0003136_yellow_coat_color | 5.86627079 |
| 3 | MP0004381_abnormal_hair_follicle | 4.56919149 |
| 4 | * MP0005408_hypopigmentation | 4.52136613 |
| 5 | MP0005257_abnormal_intraocular_pressure | 4.16893472 |
| 6 | * MP0000371_diluted_coat_color | 4.03225020 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 3.68102733 |
| 8 | MP0000015_abnormal_ear_pigmentation | 3.54598370 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 3.38122411 |
| 10 | MP0003878_abnormal_ear_physiology | 3.38122411 |
| 11 | * MP0002095_abnormal_skin_pigmentation | 2.83290453 |
| 12 | MP0002102_abnormal_ear_morphology | 2.81164537 |
| 13 | MP0005075_abnormal_melanosome_morpholog | 2.68595599 |
| 14 | MP0005174_abnormal_tail_pigmentation | 2.38181087 |
| 15 | * MP0001324_abnormal_eye_pigmentation | 2.34580234 |
| 16 | * MP0002075_abnormal_coat/hair_pigmentati | 2.34050317 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.26467131 |
| 18 | MP0005171_absent_coat_pigmentation | 10.2073949 |
| 19 | MP0003646_muscle_fatigue | 1.98334117 |
| 20 | MP0002938_white_spotting | 1.94228922 |
| 21 | MP0005248_abnormal_Harderian_gland | 1.93181492 |
| 22 | * MP0001186_pigmentation_phenotype | 1.86712765 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.86317957 |
| 24 | MP0004885_abnormal_endolymph | 1.80731206 |
| 25 | MP0002822_catalepsy | 1.48113751 |
| 26 | MP0002638_abnormal_pupillary_reflex | 1.47735549 |
| 27 | MP0005197_abnormal_uvea_morphology | 1.41100147 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.23542283 |
| 29 | MP0002090_abnormal_vision | 1.14243584 |
| 30 | MP0005409_darkened_coat_color | 1.03686060 |
| 31 | MP0010094_abnormal_chromosome_stability | 0.87377824 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 0.80582483 |
| 33 | MP0001293_anophthalmia | 0.76546680 |
| 34 | MP0000733_abnormal_muscle_development | 0.75104722 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 0.67885556 |
| 36 | MP0005058_abnormal_lysosome_morphology | 0.65510591 |
| 37 | MP0005253_abnormal_eye_physiology | 0.64173236 |
| 38 | MP0002089_abnormal_postnatal_growth/wei | 0.62707702 |
| 39 | MP0008260_abnormal_autophagy | 0.61098357 |
| 40 | MP0001485_abnormal_pinna_reflex | 0.57536045 |
| 41 | MP0009697_abnormal_copulation | 0.55045959 |
| 42 | * MP0000367_abnormal_coat/_hair | 0.53323484 |
| 43 | MP0006054_spinal_hemorrhage | 0.52632145 |
| 44 | MP0000762_abnormal_tongue_morphology | 0.50106511 |
| 45 | MP0003186_abnormal_redox_activity | 0.48965909 |
| 46 | MP0010307_abnormal_tumor_latency | 0.48596013 |
| 47 | MP0000377_abnormal_hair_follicle | 0.47792574 |
| 48 | MP0000749_muscle_degeneration | 0.46741051 |
| 49 | MP0006138_congestive_heart_failure | 0.46373331 |
| 50 | MP0005023_abnormal_wound_healing | 0.43220051 |
| 51 | MP0002177_abnormal_outer_ear | 0.42569068 |
| 52 | MP0003943_abnormal_hepatobiliary_system | 0.41547341 |
| 53 | MP0002092_abnormal_eye_morphology | 0.41219904 |
| 54 | MP0003566_abnormal_cell_adhesion | 0.40176287 |
| 55 | MP0009840_abnormal_foam_cell | 0.37267386 |
| 56 | MP0005391_vision/eye_phenotype | 0.36888439 |
| 57 | MP0005623_abnormal_meninges_morphology | 0.36199025 |
| 58 | MP0005193_abnormal_anterior_eye | 0.35867832 |
| 59 | MP0003123_paternal_imprinting | 0.34001527 |
| 60 | MP0001849_ear_inflammation | 0.32905107 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 0.30396799 |
| 62 | MP0001984_abnormal_olfaction | 0.29987769 |
| 63 | MP0000647_abnormal_sebaceous_gland | 0.29576923 |
| 64 | MP0008770_decreased_survivor_rate | 0.29410685 |
| 65 | MP0003091_abnormal_cell_migration | 0.28585638 |
| 66 | MP0005195_abnormal_posterior_eye | 0.28153348 |
| 67 | MP0003950_abnormal_plasma_membrane | 0.28097743 |
| 68 | MP0000358_abnormal_cell_content/ | 0.27155480 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 0.26063379 |
| 70 | MP0004084_abnormal_cardiac_muscle | 0.25719633 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 0.25665636 |
| 72 | MP0004233_abnormal_muscle_weight | 0.23744521 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 0.22734111 |
| 74 | MP0009046_muscle_twitch | 0.22633122 |
| 75 | MP0005386_behavior/neurological_phenoty | 0.22164443 |
| 76 | MP0004924_abnormal_behavior | 0.22164443 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 0.22108618 |
| 78 | MP0001958_emphysema | 0.21441982 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.21436928 |
| 80 | MP0003111_abnormal_nucleus_morphology | 0.20659127 |
| 81 | MP0002396_abnormal_hematopoietic_system | 0.20433746 |
| 82 | MP0004197_abnormal_fetal_growth/weight/ | 0.19528343 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.18939147 |
| 84 | MP0008569_lethality_at_weaning | 0.18380646 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.17284189 |
| 86 | MP0003634_abnormal_glial_cell | 0.16506195 |
| 87 | MP0010352_gastrointestinal_tract_polyps | 0.16400786 |
| 88 | MP0008932_abnormal_embryonic_tissue | 0.14929119 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.14687237 |
| 90 | MP0001851_eye_inflammation | 0.14566905 |
| 91 | MP0004484_altered_response_of | 0.13769224 |
| 92 | MP0001188_hyperpigmentation | 0.13704438 |
| 93 | MP0002697_abnormal_eye_size | 0.13105925 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.12580987 |
| 95 | MP0002751_abnormal_autonomic_nervous | 0.11625133 |
| 96 | MP0003385_abnormal_body_wall | 0.11298900 |
| 97 | MP0002752_abnormal_somatic_nervous | 0.11135420 |
| 98 | MP0008057_abnormal_DNA_replication | 0.11105254 |
| 99 | MP0008058_abnormal_DNA_repair | 0.09791687 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.09093150 |
| 101 | MP0000427_abnormal_hair_cycle | 0.08676597 |
| 102 | MP0000955_abnormal_spinal_cord | 0.08506078 |
| 103 | MP0000343_altered_response_to | 0.07968959 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.07877308 |
| 105 | MP0003718_maternal_effect | 0.07337320 |
| 106 | MP0001270_distended_abdomen | 0.06997970 |
| 107 | MP0005164_abnormal_response_to | 0.06817297 |
| 108 | MP0008007_abnormal_cellular_replicative | 0.06553745 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.06275318 |
| 110 | MP0003011_delayed_dark_adaptation | 0.06234058 |
| 111 | MP0001963_abnormal_hearing_physiology | 0.06000894 |
| 112 | MP0004142_abnormal_muscle_tone | 0.05988863 |
| 113 | MP0003698_abnormal_male_reproductive | 0.05971129 |
| 114 | MP0009703_decreased_birth_body | 0.05615042 |
| 115 | MP0001915_intracranial_hemorrhage | 0.05194900 |
| 116 | MP0003937_abnormal_limbs/digits/tail_de | 0.04698475 |
| 117 | MP0004147_increased_porphyrin_level | 0.04691778 |
| 118 | MP0005165_increased_susceptibility_to | 0.04010543 |
| 119 | MP0003632_abnormal_nervous_system | 0.03795792 |
| 120 | MP0003938_abnormal_ear_development | 0.03632414 |
| 121 | MP0005330_cardiomyopathy | 0.03565267 |
| 122 | MP0000920_abnormal_myelination | 0.03448798 |
| 123 | MP0000537_abnormal_urethra_morphology | 0.03122079 |
| 124 | MP0002060_abnormal_skin_morphology | 0.02941160 |
| 125 | MP0002229_neurodegeneration | 0.02844773 |
| 126 | MP0000026_abnormal_inner_ear | 0.02566058 |
| 127 | MP0005083_abnormal_biliary_tract | 0.02465468 |
| 128 | MP0005187_abnormal_penis_morphology | 0.01693939 |
| 129 | MP0002269_muscular_atrophy | 0.01458757 |
| 130 | MP0000747_muscle_weakness | 0.01411568 |
| 131 | MP0000609_abnormal_liver_physiology | -0.0167590 |
| 132 | MP0000681_abnormal_thyroid_gland | -0.0164476 |
| 133 | MP0001697_abnormal_embryo_size | -0.0163539 |
| 134 | MP0004087_abnormal_muscle_fiber | -0.0151972 |
| 135 | MP0005384_cellular_phenotype | -0.0122706 |
| 136 | MP0004272_abnormal_basement_membrane | -0.0065327 |
| 137 | MP0003077_abnormal_cell_cycle | -0.0018537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Aplasia/Hypoplasia of the macula (HP:0008059) | 9.94306885 |
| 2 | * Blue irides (HP:0000635) | 9.64244907 |
| 3 | * Aplasia/Hypoplasia affecting the retina (HP:0008061) | 9.30717391 |
| 4 | * Ocular albinism (HP:0001107) | 8.28125821 |
| 5 | White forelock (HP:0002211) | 7.31577858 |
| 6 | * Iris hypopigmentation (HP:0007730) | 7.21282107 |
| 7 | Subacute progressive viral hepatitis (HP:0006572) | 7.13687654 |
| 8 | Congenital sensorineural hearing impairment (HP:0008527) | 7.12920268 |
| 9 | Patchy hypopigmentation of hair (HP:0011365) | 6.54980038 |
| 10 | Hypoplasia of the iris (HP:0007676) | 5.81275829 |
| 11 | Cutaneous melanoma (HP:0012056) | 5.53313964 |
| 12 | * Generalized hypopigmentation (HP:0007513) | 5.31716083 |
| 13 | * Hypopigmentation of the fundus (HP:0007894) | 5.29087832 |
| 14 | Heterochromia iridis (HP:0001100) | 5.19570034 |
| 15 | Freckling (HP:0001480) | 5.15196326 |
| 16 | Congenital stationary night blindness (HP:0007642) | 4.80312556 |
| 17 | Bilateral sensorineural hearing impairment (HP:0008619) | 4.79340134 |
| 18 | Generalized hypopigmentation of hair (HP:0011358) | 4.77780961 |
| 19 | Premature graying of hair (HP:0002216) | 4.21665539 |
| 20 | Viral hepatitis (HP:0006562) | 4.09586545 |
| 21 | Micronodular cirrhosis (HP:0001413) | 3.95705220 |
| 22 | Albinism (HP:0001022) | 3.92784374 |
| 23 | Decreased central vision (HP:0007663) | 3.92014247 |
| 24 | Amblyopia (HP:0000646) | 3.73976070 |
| 25 | Hepatocellular carcinoma (HP:0001402) | 3.35709164 |
| 26 | Horizontal nystagmus (HP:0000666) | 3.18548386 |
| 27 | Melanoma (HP:0002861) | 2.78317565 |
| 28 | * Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.75909939 |
| 29 | Abnormality of the anterior horn cell (HP:0006802) | 2.53203334 |
| 30 | Degeneration of anterior horn cells (HP:0002398) | 2.53203334 |
| 31 | Peripheral hypomyelination (HP:0007182) | 2.50301118 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.50240908 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.50240908 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.50240908 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 2.47336282 |
| 36 | Abnormality of vision evoked potentials (HP:0000649) | 2.41115245 |
| 37 | Abnormal auditory evoked potentials (HP:0006958) | 2.37154564 |
| 38 | Cholecystitis (HP:0001082) | 2.23943291 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 2.23943291 |
| 40 | Tongue fasciculations (HP:0001308) | 2.20313652 |
| 41 | Frequent falls (HP:0002359) | 2.16438691 |
| 42 | Scapular winging (HP:0003691) | 2.13358619 |
| 43 | Spastic diplegia (HP:0001264) | 2.12280355 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12192424 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.12192424 |
| 46 | Rhabdomyosarcoma (HP:0002859) | 2.11601043 |
| 47 | Renal cell carcinoma (HP:0005584) | 2.10332000 |
| 48 | Hypokinesia (HP:0002375) | 2.07963603 |
| 49 | Facial cleft (HP:0002006) | 2.07211825 |
| 50 | Hypoplasia of the fovea (HP:0007750) | 12.7895374 |
| 51 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 12.7895374 |
| 52 | Abnormality of the fovea (HP:0000493) | 10.6003144 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 1.94158703 |
| 54 | Synophrys (HP:0000664) | 1.91483330 |
| 55 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90690071 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90690071 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90690071 |
| 58 | Muscle fibrillation (HP:0010546) | 1.88018680 |
| 59 | Underdeveloped nasal alae (HP:0000430) | 1.85787939 |
| 60 | Cerebral hypomyelination (HP:0006808) | 1.84365874 |
| 61 | Visual hallucinations (HP:0002367) | 1.83822073 |
| 62 | Hypermelanotic macule (HP:0001034) | 1.82579265 |
| 63 | Fibular hypoplasia (HP:0003038) | 1.80895854 |
| 64 | Astigmatism (HP:0000483) | 1.80421242 |
| 65 | Hepatitis (HP:0012115) | 1.79265963 |
| 66 | Melanocytic nevus (HP:0000995) | 1.76855287 |
| 67 | Vertebral compression fractures (HP:0002953) | 1.73075030 |
| 68 | Loss of speech (HP:0002371) | 1.69221593 |
| 69 | Dysostosis multiplex (HP:0000943) | 1.68310698 |
| 70 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.67797946 |
| 71 | Tented upper lip vermilion (HP:0010804) | 1.64075423 |
| 72 | Epidermoid cyst (HP:0200040) | 1.63448211 |
| 73 | Adrenal hypoplasia (HP:0000835) | 1.61523673 |
| 74 | Abnormality of glycolysis (HP:0004366) | 1.59242532 |
| 75 | Aplasia cutis congenita (HP:0001057) | 1.58291101 |
| 76 | Morphological abnormality of the inner ear (HP:0011390) | 1.56990280 |
| 77 | Alacrima (HP:0000522) | 1.55672702 |
| 78 | Conjunctival hamartoma (HP:0100780) | 1.55292176 |
| 79 | Abnormality of the anterior chamber (HP:0000593) | 1.51787061 |
| 80 | Abnormality of the pupil (HP:0000615) | 1.47764716 |
| 81 | Exercise-induced muscle cramps (HP:0003710) | 1.46838460 |
| 82 | Hamartoma of the eye (HP:0010568) | 1.45626221 |
| 83 | Hand muscle atrophy (HP:0009130) | 1.44208245 |
| 84 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.43748793 |
| 85 | Neoplasm of the liver (HP:0002896) | 1.43648972 |
| 86 | Neoplasm of striated muscle (HP:0009728) | 1.43396407 |
| 87 | Supernumerary ribs (HP:0005815) | 1.42764780 |
| 88 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.42655045 |
| 89 | Absent epiphyses (HP:0010577) | 1.42655045 |
| 90 | Narrow nasal bridge (HP:0000446) | 1.42017522 |
| 91 | Myelomeningocele (HP:0002475) | 1.41709383 |
| 92 | J-shaped sella turcica (HP:0002680) | 1.41170546 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.41076251 |
| 94 | Poor head control (HP:0002421) | 1.40668042 |
| 95 | Dyschromatopsia (HP:0007641) | 1.40612023 |
| 96 | Lip pit (HP:0100267) | 1.40194166 |
| 97 | Impaired proprioception (HP:0010831) | 1.38457325 |
| 98 | Large for gestational age (HP:0001520) | 1.38338423 |
| 99 | Diminished movement (HP:0002374) | 1.37271260 |
| 100 | Spastic paraplegia (HP:0001258) | 1.35852595 |
| 101 | Long toe (HP:0010511) | 1.35811640 |
| 102 | Cerebral aneurysm (HP:0004944) | 1.35605412 |
| 103 | Increased cerebral lipofuscin (HP:0011813) | 1.34927485 |
| 104 | Decreased lacrimation (HP:0000633) | 1.31139319 |
| 105 | Ulnar deviation of finger (HP:0009465) | 1.29907795 |
| 106 | Skin nodule (HP:0200036) | 1.26728171 |
| 107 | Megalencephaly (HP:0001355) | 1.26231898 |
| 108 | Akinesia (HP:0002304) | 1.25228408 |
| 109 | Tracheomalacia (HP:0002779) | 1.23956457 |
| 110 | Spinal muscular atrophy (HP:0007269) | 1.23438944 |
| 111 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.21927809 |
| 112 | Overlapping toe (HP:0001845) | 1.21855676 |
| 113 | Intestinal atresia (HP:0011100) | 1.20793459 |
| 114 | Synostosis of carpal bones (HP:0005048) | 1.20019669 |
| 115 | Hypermetropia (HP:0000540) | 1.19399901 |
| 116 | Paraparesis (HP:0002385) | 1.19318145 |
| 117 | Paraplegia (HP:0010550) | 1.19299012 |
| 118 | Abnormal pupillary function (HP:0007686) | 1.18743301 |
| 119 | Morphological abnormality of the middle ear (HP:0008609) | 1.18354615 |
| 120 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.18288944 |
| 121 | Abnormality of the nasal septum (HP:0000419) | 1.17731589 |
| 122 | Upper limb amyotrophy (HP:0009129) | 1.17279494 |
| 123 | Distal upper limb amyotrophy (HP:0007149) | 1.17279494 |
| 124 | Delusions (HP:0000746) | 1.16254769 |
| 125 | Leukodystrophy (HP:0002415) | 1.15613457 |
| 126 | Atelectasis (HP:0100750) | 1.15495254 |
| 127 | * Photophobia (HP:0000613) | 1.15237894 |
| 128 | Aortic aneurysm (HP:0004942) | 1.14377492 |
| 129 | Asymmetry of the thorax (HP:0001555) | 1.13932138 |
| 130 | Coarse hair (HP:0002208) | 1.12264693 |
| 131 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.11172219 |
| 132 | Neoplasm of head and neck (HP:0012288) | 1.10709003 |
| 133 | Esophageal neoplasm (HP:0100751) | 1.10709003 |
| 134 | Long clavicles (HP:0000890) | 1.10552107 |
| 135 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.09694072 |
| 136 | Prolonged neonatal jaundice (HP:0006579) | 1.08886763 |
| 137 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.08790256 |
| 138 | Spastic paraparesis (HP:0002313) | 1.08519278 |
| 139 | Vascular tortuosity (HP:0004948) | 1.06831472 |
| 140 | Proximal amyotrophy (HP:0007126) | 1.06665192 |
| 141 | Fatigue (HP:0012378) | 1.06556415 |
| 142 | Carpal synostosis (HP:0009702) | 1.06390598 |
| 143 | Distal sensory impairment (HP:0002936) | 1.06018628 |
| 144 | Subaortic stenosis (HP:0001682) | 1.05152763 |
| 145 | Premature rupture of membranes (HP:0001788) | 1.03289839 |
| 146 | Hypopigmented skin patches (HP:0001053) | 1.01958513 |
| 147 | Upper limb muscle weakness (HP:0003484) | 1.01562163 |
| 148 | Ovoid vertebral bodies (HP:0003300) | 1.01525864 |
| 149 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.00615847 |
| 150 | Deep venous thrombosis (HP:0002625) | 1.00263038 |
| 151 | Exostoses (HP:0100777) | 0.99869531 |
| 152 | Bladder diverticulum (HP:0000015) | 0.97432914 |
| 153 | Cutaneous finger syndactyly (HP:0010554) | 0.96118810 |
| 154 | Bladder carcinoma (HP:0002862) | 0.95573552 |
| 155 | Bladder neoplasm (HP:0009725) | 0.95573552 |
| 156 | Spontaneous hematomas (HP:0007420) | 0.93536247 |
| 157 | Acrocyanosis (HP:0001063) | 0.93147425 |
| 158 | Hydroxyprolinuria (HP:0003080) | 0.93119270 |
| 159 | Abnormality of proline metabolism (HP:0010907) | 0.93119270 |
| 160 | Abnormality of the antihelix (HP:0009738) | 0.91550726 |
| 161 | Decreased motor nerve conduction velocity (HP:0003431) | 0.91282544 |
| 162 | Leiomyosarcoma (HP:0100243) | 0.90778673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MET | 5.69369584 |
| 2 | PDK2 | 4.91808246 |
| 3 | MARK3 | 4.00256675 |
| 4 | BMX | 3.98370399 |
| 5 | PKN2 | 3.67439233 |
| 6 | EIF2AK1 | 3.14157506 |
| 7 | WEE1 | 3.07536034 |
| 8 | PRKCH | 2.84827277 |
| 9 | TRIB3 | 2.53421318 |
| 10 | MAP3K3 | 2.32119175 |
| 11 | BMPR1B | 2.29527274 |
| 12 | SIK3 | 2.18014845 |
| 13 | EPHA3 | 2.10843515 |
| 14 | MST1R | 13.3476337 |
| 15 | PTK2B | 1.73086748 |
| 16 | ERBB3 | 1.71275639 |
| 17 | BMPR2 | 1.65706895 |
| 18 | GRK6 | 1.59395433 |
| 19 | SCYL2 | 1.57921475 |
| 20 | GRK5 | 1.41594802 |
| 21 | EIF2AK3 | 1.41287217 |
| 22 | PRKD3 | 1.39334685 |
| 23 | TRIM28 | 1.38620257 |
| 24 | ACVR1B | 1.35940407 |
| 25 | NME2 | 1.32660544 |
| 26 | MAPKAPK3 | 1.19772075 |
| 27 | PLK3 | 1.15585676 |
| 28 | CDK3 | 1.14929417 |
| 29 | DDR2 | 1.10726941 |
| 30 | LATS1 | 1.01275819 |
| 31 | PRKD1 | 1.00193824 |
| 32 | FLT3 | 0.93193736 |
| 33 | NEK6 | 0.90440450 |
| 34 | ICK | 0.88439444 |
| 35 | PTK6 | 0.84213739 |
| 36 | TGFBR2 | 0.82163798 |
| 37 | BRSK1 | 0.81726809 |
| 38 | SIK2 | 0.81083725 |
| 39 | NEK1 | 0.79741817 |
| 40 | GSK3A | 0.78405641 |
| 41 | TTN | 0.77813849 |
| 42 | LRRK2 | 0.71561055 |
| 43 | ABL2 | 0.71276548 |
| 44 | CAMKK1 | 0.67046391 |
| 45 | MATK | 0.63666384 |
| 46 | ATR | 0.63269657 |
| 47 | KIT | 0.63031060 |
| 48 | LIMK1 | 0.62973309 |
| 49 | CSNK1G1 | 0.61822470 |
| 50 | KSR2 | 0.57105557 |
| 51 | CSNK1G3 | 0.56742544 |
| 52 | RET | 0.55633655 |
| 53 | MAP3K2 | 0.54584514 |
| 54 | CSNK1A1L | 0.53785366 |
| 55 | ADRBK1 | 0.53198153 |
| 56 | DYRK1A | 0.53101132 |
| 57 | PLK1 | 0.52870138 |
| 58 | KSR1 | 0.51847661 |
| 59 | PAK4 | 0.46663460 |
| 60 | RPS6KB2 | 0.44669410 |
| 61 | FER | 0.43493160 |
| 62 | CSNK1G2 | 0.42628250 |
| 63 | ILK | 0.40625714 |
| 64 | EGFR | 0.39774306 |
| 65 | TGFBR1 | 0.38905906 |
| 66 | ERBB2 | 0.38744212 |
| 67 | FGFR4 | 0.38585575 |
| 68 | CAMKK2 | 0.38534864 |
| 69 | MAP4K2 | 0.38424852 |
| 70 | STK38 | 0.37826434 |
| 71 | MAP3K13 | 0.37100033 |
| 72 | PDGFRA | 0.36692683 |
| 73 | PRKG2 | 0.36133933 |
| 74 | TSSK6 | 0.35922147 |
| 75 | BRD4 | 0.35840213 |
| 76 | MAP3K9 | 0.35536712 |
| 77 | TBK1 | 0.35435079 |
| 78 | RIPK1 | 0.35174455 |
| 79 | ERBB4 | 0.34958581 |
| 80 | EEF2K | 0.33017985 |
| 81 | MAPK10 | 0.32909816 |
| 82 | AKT2 | 0.32229572 |
| 83 | CSNK1A1 | 0.31606381 |
| 84 | ATM | 0.31474150 |
| 85 | PAK6 | 0.30974445 |
| 86 | CLK1 | 0.30496860 |
| 87 | CDK7 | 0.29229636 |
| 88 | ZAP70 | 0.29108973 |
| 89 | PRKCE | 0.27928320 |
| 90 | CDK18 | 0.26836113 |
| 91 | PRKCG | 0.26564758 |
| 92 | TYK2 | 0.25993281 |
| 93 | PRKCZ | 0.25954162 |
| 94 | LMTK2 | 0.25900238 |
| 95 | INSR | 0.25767028 |
| 96 | MAP2K1 | 0.25645220 |
| 97 | CDK6 | 0.25457717 |
| 98 | CCNB1 | 0.23269121 |
| 99 | CAMK2A | 0.23251551 |
| 100 | RAF1 | 0.22884139 |
| 101 | KDR | 0.22572525 |
| 102 | DMPK | 0.22152314 |
| 103 | MAP3K8 | 0.21464990 |
| 104 | BCKDK | 0.21341183 |
| 105 | MAP3K11 | 0.20935299 |
| 106 | CDC7 | 0.20803843 |
| 107 | FRK | 0.20616654 |
| 108 | CDK11A | 0.19601425 |
| 109 | CDK15 | 0.17881021 |
| 110 | FGFR3 | 0.17779941 |
| 111 | TLK1 | 0.16927736 |
| 112 | FGR | 0.16671791 |
| 113 | SIK1 | 0.16605375 |
| 114 | ALK | 0.16306396 |
| 115 | STK4 | 0.15782333 |
| 116 | CHEK2 | 0.15297585 |
| 117 | CSNK2A1 | 0.15283375 |
| 118 | CAMK1D | 0.15008283 |
| 119 | NTRK1 | 0.14993023 |
| 120 | LATS2 | 0.14469291 |
| 121 | SGK3 | 0.13704508 |
| 122 | RPS6KA1 | 0.13568541 |
| 123 | TTK | 0.13253802 |
| 124 | TYRO3 | 0.13164465 |
| 125 | ARAF | 0.12167864 |
| 126 | MAPK12 | 0.12127857 |
| 127 | IGF1R | 0.12062259 |
| 128 | CDK4 | 0.11403430 |
| 129 | ABL1 | 0.11286249 |
| 130 | SGK2 | 0.11181672 |
| 131 | PLK2 | 0.10744437 |
| 132 | FGFR1 | 0.10272970 |
| 133 | STK3 | 0.10173784 |
| 134 | BRSK2 | 0.10160664 |
| 135 | SRC | 0.09534857 |
| 136 | PAK3 | 0.09239882 |
| 137 | BLK | 0.09081689 |
| 138 | MAPK3 | 0.09057122 |
| 139 | PDGFRB | 0.08703847 |
| 140 | PAK2 | 0.08655222 |
| 141 | CSNK1D | 0.07873174 |
| 142 | NEK2 | 0.07360043 |
| 143 | PTK2 | 0.06845712 |
| 144 | MAP4K1 | 0.06413460 |
| 145 | PRKACB | 0.06374932 |
| 146 | PRKAA2 | 0.06242304 |
| 147 | EPHB1 | 0.05972959 |
| 148 | DYRK1B | 0.05825056 |
| 149 | MOS | 0.05488688 |
| 150 | ZAK | 0.05232138 |
| 151 | TRPM7 | 0.04812155 |
| 152 | FGFR2 | 0.04043760 |
| 153 | AKT1 | 0.02998163 |
| 154 | MAPK11 | 0.02807559 |
| 155 | MAP2K6 | 0.02367482 |
| 156 | PDK1 | 0.02361905 |
| 157 | LYN | 0.02241039 |
| 158 | NEK9 | 0.02221805 |
| 159 | WNK4 | 0.01962609 |
| 160 | PRKCQ | 0.01918867 |
| 161 | NUAK1 | 0.01671103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 4.12373566 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.03074753 |
| 3 | Melanogenesis_Homo sapiens_hsa04916 | 3.95102755 |
| 4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.65021781 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 3.32635603 |
| 6 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 2.76377584 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.50751192 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.43124969 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39558373 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.28148725 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.23661090 |
| 12 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.16267583 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.10640467 |
| 14 | Melanoma_Homo sapiens_hsa05218 | 2.07589923 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.05317787 |
| 16 | Renal cell carcinoma_Homo sapiens_hsa05211 | 2.01833431 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 10.2401160 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.92715757 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.88327997 |
| 20 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.84408042 |
| 21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.81644220 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.76322496 |
| 23 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.73949044 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.69404774 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68910692 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52523118 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.51903455 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.51583058 |
| 29 | Adherens junction_Homo sapiens_hsa04520 | 1.45704033 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44993188 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43969010 |
| 32 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.34726876 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.32863731 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31729009 |
| 35 | Huntingtons disease_Homo sapiens_hsa05016 | 1.22805265 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.18150601 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12932327 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10762330 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06577091 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06557055 |
| 41 | Mismatch repair_Homo sapiens_hsa03430 | 1.06232679 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.04100071 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03263719 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00679930 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99628841 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95290974 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94173003 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93904216 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 0.90831814 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.89957476 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89835417 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.89557162 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89075129 |
| 54 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.88146706 |
| 55 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85164513 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82179376 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80956609 |
| 58 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76643874 |
| 59 | Alcoholism_Homo sapiens_hsa05034 | 0.76556663 |
| 60 | Cell cycle_Homo sapiens_hsa04110 | 0.76402510 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.73251161 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.71042800 |
| 63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70109239 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69958633 |
| 65 | Axon guidance_Homo sapiens_hsa04360 | 0.69761683 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69267502 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68865190 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68536982 |
| 69 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.67861577 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66540079 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66218753 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63857965 |
| 73 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63722033 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63279797 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62438775 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62163948 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59769585 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56967059 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56278887 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54139569 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53975447 |
| 82 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.53957336 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.53069920 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.50605150 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.50124734 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49939939 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48165661 |
| 88 | Base excision repair_Homo sapiens_hsa03410 | 0.47169594 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46393771 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46086463 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.45993156 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45641879 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45546352 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45387970 |
| 95 | DNA replication_Homo sapiens_hsa03030 | 0.44447234 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43922850 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.43748942 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43672847 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43194352 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42498711 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42048946 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41825128 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41440666 |
| 104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41151396 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40999717 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.39360379 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38036256 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37858633 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35662354 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34894780 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34890589 |
| 112 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34783118 |
| 113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34129500 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.33980427 |
| 115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33822941 |
| 116 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.33785122 |
| 117 | RNA polymerase_Homo sapiens_hsa03020 | 0.33098237 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32444267 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30777093 |
| 120 | RNA degradation_Homo sapiens_hsa03018 | 0.30447680 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30371768 |
| 122 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.29986629 |
| 123 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.29435631 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26434940 |
| 125 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.26420819 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25130634 |
| 127 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.24843358 |
| 128 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24832424 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.24406551 |
| 130 | Hepatitis B_Homo sapiens_hsa05161 | 0.24126924 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.23120469 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.22062445 |
| 133 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.21838173 |
| 134 | Insulin resistance_Homo sapiens_hsa04931 | 0.21398625 |
| 135 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.21070683 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.21017219 |
| 137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20688733 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20552267 |
| 139 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20426017 |
| 140 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.20330408 |
| 141 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20243602 |
| 142 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19167042 |
| 143 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.18704187 |
| 144 | Pathways in cancer_Homo sapiens_hsa05200 | 0.18597715 |
| 145 | Tight junction_Homo sapiens_hsa04530 | 0.18044122 |
| 146 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.17772262 |
| 147 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17593236 |
| 148 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.16683245 |
| 149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16159902 |
| 150 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.16126935 |
| 151 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.13034467 |
| 152 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.12339138 |
| 153 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.10671263 |
| 154 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.09390521 |
| 155 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08289964 |
| 156 | Mineral absorption_Homo sapiens_hsa04978 | 0.07666671 |

